News for Novanta Inc. (0VAG.L)

Comprehensive SWOT analysis based on Novanta Inc's latest SEC 10-K filing.Deep dive into Novanta's competitive advantages, market position, and growth strategi

PR NewswireSANTA ANA, Calif., Feb. 27, 2025 Identiv and Novanta to market new RFID-based solutions that fill much needed gap for medical device and pharmac

Fourth Quarter Revenue: $238 million, 3% organic growth year-over-year, 13% reported revenue growth.Full Year 2024 Revenue: $949 million, 8% reported revenue g

Feb 25, 2025 / 03:00PM GMTOperator Good morning. My name is Gary, and I will be your conference operator today. At this time, I would like to welcome everyone t

Novanta Inc. (NASDAQ:NOVT) Q4 2024 Earnings Call February 25, 2025 10:00 AM ETCompany ParticipantsRay Nash - Investor RelationsMatthijs Glastra - Chair and...

Fourth Quarter 2024 GAAP Revenue increased 13% to $238 million, including $2 million unfavorable FX impact Fourth Quarter 2024 GAAP Diluted EPS of $0.46 and Adjus…

We recently published a list of 12 Best Scientific Instruments Stocks to Buy Right Now. In this article, we are going to take a look at where Novanta Inc.

The global scientific instruments market has been experiencing steady growth and is expected to continue its upward trajectory in the coming years.

IDEX Corp (IEX) has announced the appointment of Stephanie Disher and Matthijs Glastra to its Board of Directors, effective February 21, 2025. This strategic mo

U.S. equity indices generated modest returns in the fourth quarter of 2024, and closed out the full year with double digit returns for the second year in a row.

We have downgraded Novanta from hold to sell due to weakening demand, high debt levels, and overvaluation compared to peers. Read an analysis of NOVT stock here.

BEDFORD, Mass. — Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced to…

BEDFORD, Mass. — Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced to…

Novanta CFO Robert Buckley sells $275,148 in stock

Novanta CEO Matthijs Glastra sells $337,016 in stock

Shares of Novanta Inc (NOVT) surged 3.38% in mid-day trading on Nov 25. The stock reached an intraday high of $175.83, before settling at $175.53, up from i

Novanta CFO Robert Buckley sells $660,184 in common stock

Earnings call: Novanta reports robust Q3 with revenue up 10%

Revenue: $244 million, 10% reported growth, flat organic growth.Adjusted Gross Margin: 46%, up 70 basis points excluding Motion Solutions acquisition impact.Ad